New hope for dialysis patients: TS-172 targets dangerous phosphorus levels
NCT ID NCT07548853
First seen May 05, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests an experimental drug called TS-172 in 30 adults with high phosphorus levels who are on peritoneal dialysis. The goal is to see if TS-172 can help bring phosphorus levels down to a safer range. Participants will take the drug and have regular blood tests to check phosphorus, calcium, and other related measures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taisho Selected Site
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.